Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
4446 | 1710 | 40.7 | 51% |
Classes in level above (level 2) |
ID, lev. above |
Publications | Label for level above |
---|---|---|
2216 | 4340 | ORTHO PHENYLPHENOL//SEX DISCRIMINATION OF CANCER RISK//HEPATOCARCINOGENESIS |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | MEDIUM TERM BIOASSAY | Author keyword | 7 | 53% | 1% | 10 |
2 | INITIATION ASSAY | Author keyword | 6 | 80% | 0% | 4 |
3 | HEPATIC PRENEOPLASIA | Author keyword | 6 | 71% | 0% | 5 |
4 | ENZYME ALTERED FOCI | Author keyword | 6 | 47% | 1% | 9 |
5 | TRANS 4 ACETYLAMINOSTILBENE | Author keyword | 6 | 100% | 0% | 4 |
6 | SEZ PATOL SPERIMENTALE ONCOL | Address | 5 | 60% | 0% | 6 |
7 | FOCI OF ALTERED HEPATOCYTES | Author keyword | 5 | 54% | 0% | 7 |
8 | GST P POSITIVE FOCI | Author keyword | 5 | 38% | 1% | 10 |
9 | DIETHYLNITROSAMINE | Author keyword | 4 | 13% | 2% | 33 |
10 | HEPATIC FOCI | Author keyword | 4 | 67% | 0% | 4 |
Web of Science journal categories |
Author Key Words |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
LCSH search | Wikipedia search |
---|---|---|---|---|---|---|---|
1 | MEDIUM TERM BIOASSAY | 7 | 53% | 1% | 10 | Search MEDIUM+TERM+BIOASSAY | Search MEDIUM+TERM+BIOASSAY |
2 | INITIATION ASSAY | 6 | 80% | 0% | 4 | Search INITIATION+ASSAY | Search INITIATION+ASSAY |
3 | HEPATIC PRENEOPLASIA | 6 | 71% | 0% | 5 | Search HEPATIC+PRENEOPLASIA | Search HEPATIC+PRENEOPLASIA |
4 | ENZYME ALTERED FOCI | 6 | 47% | 1% | 9 | Search ENZYME+ALTERED+FOCI | Search ENZYME+ALTERED+FOCI |
5 | TRANS 4 ACETYLAMINOSTILBENE | 6 | 100% | 0% | 4 | Search TRANS+4+ACETYLAMINOSTILBENE | Search TRANS+4+ACETYLAMINOSTILBENE |
6 | FOCI OF ALTERED HEPATOCYTES | 5 | 54% | 0% | 7 | Search FOCI+OF+ALTERED+HEPATOCYTES | Search FOCI+OF+ALTERED+HEPATOCYTES |
7 | GST P POSITIVE FOCI | 5 | 38% | 1% | 10 | Search GST+P+POSITIVE+FOCI | Search GST+P+POSITIVE+FOCI |
8 | DIETHYLNITROSAMINE | 4 | 13% | 2% | 33 | Search DIETHYLNITROSAMINE | Search DIETHYLNITROSAMINE |
9 | HEPATIC FOCI | 4 | 67% | 0% | 4 | Search HEPATIC+FOCI | Search HEPATIC+FOCI |
10 | PRENEOPLASTIC HEPATOCYTES | 4 | 67% | 0% | 4 | Search PRENEOPLASTIC+HEPATOCYTES | Search PRENEOPLASTIC+HEPATOCYTES |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | DIETHYLNITROSAMINE | 26 | 24% | 6% | 95 |
2 | HEPATOCARCINOGENESIS | 24 | 11% | 13% | 217 |
3 | BIOCHEMICAL MICROANALYSIS | 23 | 86% | 1% | 12 |
4 | ALTERED HEPATIC FOCI | 20 | 40% | 2% | 40 |
5 | ALTERED FOCI | 17 | 41% | 2% | 33 |
6 | N NITROSOMORPHOLINE | 17 | 42% | 2% | 31 |
7 | HEPATOCELLULAR FOCI | 15 | 88% | 0% | 7 |
8 | ENZYME ALTERED FOCI | 15 | 32% | 2% | 37 |
9 | MULTISTAGE HEPATOCARCINOGENESIS | 13 | 49% | 1% | 20 |
10 | HEPATOCELLULAR GLYCOGENOSIS | 13 | 80% | 0% | 8 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
HEPATOCARCINOGENESIS - A DYNAMIC CELLULAR PERSPECTIVE | 1987 | 361 | 65 | 71% |
ALTERED HEPATIC FOCI - THEIR ROLE IN MURINE HEPATOCARCINOGENESIS | 1990 | 156 | 169 | 77% |
Phenobarbital mechanistic data and risk assessment: Enzyme induction, enhanced cell proliferation, and tumor promotion | 1996 | 133 | 146 | 45% |
CLONAL ADAPTATION DURING CARCINOGENESIS | 1990 | 151 | 48 | 58% |
Paradoxical effects of phenobarbital on mouse hepatocarcinogenesis | 2000 | 38 | 46 | 74% |
A medium-term rat liver bioassay for rapid in vivo detection of carcinogenic potential of chemicals | 2003 | 84 | 22 | 36% |
N-nitrosodiethylamine mechanistic data and risk assessment: Bioactivation, DNA-Adduct formation, mutagenicity, and tumor initiation | 1996 | 155 | 68 | 29% |
FACTS AND THEORIES CONCERNING THE MECHANISMS OF CARCINOGENESIS | 1991 | 148 | 38 | 39% |
Adventures in hepatocarcinogenesis | 2007 | 20 | 79 | 44% |
PRENEOPLASTIC LESIONS AS END-POINTS IN CARCINOGENICITY TESTING .1. HEPATIC PRENEOPLASIA | 1986 | 146 | 55 | 87% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | SEZ PATOL SPERIMENTALE ONCOL | 5 | 60% | 0.4% | 6 |
2 | OCCUPAT TOXICOL GRP | 4 | 75% | 0.2% | 3 |
3 | DIET NUTR CANC | 4 | 33% | 0.5% | 9 |
4 | ABT CYTOPATHOL | 3 | 45% | 0.3% | 5 |
5 | ABT KREBSFOR | 2 | 67% | 0.1% | 2 |
6 | MED MCARDLE CANC | 2 | 50% | 0.2% | 3 |
7 | ORGAN FUNCT | 2 | 50% | 0.2% | 3 |
8 | ABT CYTOPATHOL 0310 | 1 | 100% | 0.1% | 2 |
9 | UNITE BIOCHEM TOXICOL CANCEROL | 1 | 100% | 0.1% | 2 |
10 | TUMORBIOL KREBSFOR | 1 | 19% | 0.2% | 4 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000152533 | MOVEMENT ACTIVITY//PIPERONYL BUTOXIDE//CYP1A INDUCER |
2 | 0.0000119778 | S 1 2 DICARBOXYETHYLGLUTATHIONE//ALPHA2 ADRENERGIC RESPONSE//BIOCHEM PHARMACOL GRP |
3 | 0.0000105337 | HA RAS//MIHALY PEKAR MED LIFE SCI LIB//HISTOL PATHOL ANAT SECT |
4 | 0.0000101638 | PEROXISOME PROLIFERATORS//PEROXISOME PROLIFERATOR//3 THIA FATTY ACIDS |
5 | 0.0000086915 | MVK MODEL//CLONAL GROWTH MODEL//TSCE MODEL |
6 | 0.0000084693 | AMPHIREGULIN AREG//IDOXIFENE//DIGEST CARDIOVASC MED |
7 | 0.0000081655 | METHAPYRILENE//ACRIVASTINE//METHAPYRILENE HYDROCHLORIDE |
8 | 0.0000080128 | BUTYLATED HYDROXYTOLUENE//BUTYLATED HYDROXYANISOLE//2 6 DI TERT BUTYL 4 METHYLPHENYL N METHYLCARBAMATE |
9 | 0.0000075701 | CELL TRANSFORMATION ASSAY//BHAS 42 CELLS//BALB C 3T3 CELL LINE |
10 | 0.0000072052 | ORTHO PHENYLPHENOL//XANTHINE OXIDOREDUCTASE INHIBITOR//EVALUAT ENVIRONM IMPACT HUMAN HLTH TOXICAM |